With the support of the leaders of the Ministry of Science and Technology and the Ministry of Health, and under the specific organization of Tianjin Science and Technology Commission, the Joint Research Institute has given full play to its own institutional mechanism and overseas talents' technological advantages, and jointly declared and undertaken the "comprehensive platform project" of major national innovative drugs with outstanding Industry-University-Research units in Tianjin. Around this task, four core technology platforms have been built in the R&D building of the Joint Research Institute, and seven supporting technology platforms have been built based on the advantageous Industry-University-Research institutions in Tianjin. The supporting technical platforms are all located in the "window" office in the building of the Joint Research Institute. In this way, with the Joint Research Institute as the core, a standardized, serialized and internationalized technical service system for new drug research has been established, which has created favorable conditions for attracting more outstanding overseas talents and made Binhai New Area the most important gathering area for biomedical innovation and industrialization in China.
The Joint Research Institute for Talents always takes the introduction of outstanding talents and projects at home and abroad as the top priority, and sincerely invites outstanding talents in the biomedical field at home and abroad to come here with R&D and industrialization projects with clear intellectual property rights in biomedical fields such as drugs, vaccines, clinical detection reagents and medical devices. The joint research institute will accelerate the process of new drug discovery to industrialization through a one-stop, complete service system and professional public technology service platform.